Distinct tau PET imaging patterns in typical and atypical Alzheimer's disease

Brain

Volumn 139, Issue 5, 2016, Pages 1321-1324

  Sarazin, Marie ^a   Lagarde, Julien ^a   Bottlaender, Michel ^b  

^a CENTRE DE PSYCHIATRIE ET NEUROSCIENCES   (France)

^b SERVICE HOSPITALIER FRÉDÉRIC JOLIOT   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; APOLIPOPROTEIN E4; BIOLOGICAL MARKER; FLUORODEOXYGLUCOSE F 18; PITTSBURGH COMPOUND B; TAU PROTEIN; TRACER;

AGNOSIA; ALZHEIMER DISEASE; APHASIA; APRAXIA; BRAIN CORTEX ATROPHY; BRAIN CORTEX LESION; COGNITION; DISEASE COURSE; ENTORHINAL CORTEX; EPISODIC MEMORY; GLUCOSE METABOLISM; HUMAN; NERVE CELL DEGENERATION; NERVE CELL LESION; NONHUMAN; NOTE; PAIRED HELICAL FILAMENT; PARAHIPPOCAMPAL GYRUS; POSITRON EMISSION TOMOGRAPHY; PRIMARY PROGRESSIVE APHASIA; PRIORITY JOURNAL; PROTEINOSIS; SENILE PLAQUE; TAUOPATHY; TEMPORAL LOBE; BRAIN;

ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; BRAIN; HUMANS; POSITRON-EMISSION TOMOGRAPHY; TAU PROTEINS;

EID: 84966565211     PISSN: 00068950     EISSN: 14602156     Source Type: Journal    
DOI: 10.1093/brain/aww041     Document Type: Note

References (12)

1. Albert MS, DeKosky ST, Dickson D, Dubois B, Feldman HH, Fox NC, et al. The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 2011; 7: 270-9.
2. Alladi S, Xuereb J, Bak T, Nestor P, Knibb J, Patterson K, et al. Focal cortical presentations of Alzheimer's disease. Brain 2007; 130: 2636-45.
3. De Souza LC, Corlier F, Habert MO, Uspenskaya O, Maroy R, Lamari F, et al. Similar amyloid-beta burden in posterior cortical atrophy and Alzheimer's disease. Brain 2011; 134: 2036-43.
4. Duyckaerts C Tau pathology in children and young adults: can you still be unconditionally baptist Acta Neuropathol 2011; 121: 145-7.
5. Eisele YS, Duyckaerts C Propagation of Ass pathology: hypotheses, discoveries, and yet unresolved questions from experimental and human brain studies. Acta Neuropathol 2016; 131: 5-25.
6. Hamelin L, Bertoux M, Bottlaender M, Corne H, Lagarde J, Hahn V, et al. Sulcal morphology as a new imaging marker for the diagnosis of early onset Alzheimer's disease. Neurobiol Aging 2015; 36: 2932-9.
7. Johnson KA, Schultz A, Betensky RA, Becker JA, Sepulcre J, Rentz D, et al. Tau PET imaging in aging and early Alzheimer's disease. Ann Neuro 2016; 79: 110-19.
8. Marquié M, Normandin MD, Vanderburg CR, Costantino IM, Bien EA, Rycyna LG, et al. Validating novel tau positron emission tomography tracer [F-18]-AV-1451 (T807) on postmortem brain tissue. Ann Neurol 2015; 78: 787-800.
9. Ossenkoppele R, Schonhaut D, Schö ll M, Lockhart S, Ayakta N, Baker S, et al. Tau PET patterns mirror clinical and neuroanatomical variability in Alzheimer's disease. Brain 2016.
10. Rabinovici GD, Furst AJ, Alkalay A, Racine CA, O'Neil JP, Janabi M, et al. Increased metabolic vulnerability in early-onset Alzheimer's disease is not related to amyloid burden. Brain 2010; 133: 512-28.
11. Villemagne VL, Fodero-Tavoletti MT, Masters CL, Rowe CC Tau imaging: early progress and future directions. Lancet Neurol 2015; 14: 114-24.
12. Whitwell JL, Dickson DW, Murray ME, Weigand SD, Tosakulwong N, Senjem ML, et al. Neuroimaging correlates of pathologically defined subtypes of Alzheimer's disease: a case-control study. Lancet Neurol 2012; 11: 868-77.